The IFCC Awarding Committee has sent a call awards for 10 reputable IFCC awards and those will be awarded at the IFCC Congress in May 2020, Seoul, Korea.
Awards will be awarded to scientists and clinicians working in laboratory medicine or related disciplines worldwide as a recognition for outstanding achievements, their publication and other contributions that have improved or stimulated others to improve and promote clinical chemistry and laboratory medicine.
All details about prizes and candidacy can be read in the letter of prof. Maurizio Ferrari, Chairman of the IFCC Awards and Helmet Committee and in the leaflet.
If you believe you can run for one of these awards, or one of our colleagues deserves it, please make sure that your suggestions or candidatures should include: (1) a statement on the reasons for the candidacy, (2) a complete CV including the bibliography and (3) other letters of support (electronically) by 2 November 2019, at the e-mail address of dr. sc. Jasna Leniček Krleža: This email address is being protected from spambots. You need JavaScript enabled to view it., in order to get the necessary letter of support from HDMBLM.
In the case of multiple applicants for the same award, main board of HDMBLM will decide on the attached documents on which candidate will give the letter of support and send it to the address of the person responsible for applying for the IFCC award.

Committee for information and public relations

Dear members,

The database, produced by the EFLM WG “Biological Variation” (Chair: Aasne Karine Aarsand) and the EFLM TG “Biological Variation Database” (Chair: Sverre Sandberg) was launched at the EuroMedLab Congress in Barcelona.

The database, available via EFLM homepage or directly at https://biologicalvariation.eu, delivers updated evidence-based biological variation (BV) estimates to users worldwide.

Abstract:
BV data are reference data that have many applications in laboratory medicine. The data describe the variability of clinically important measurands around homeostatic set points within subjects (CVI) and between subjects (CVG). The availability of well characterised data enables the interpretation of laboratory results in clinical settings and can be used to define analytical performance specifications (APS) and other applications. The literature describing studies of BV stretches back over 45 years. Reviews of BV data identify widely varying estimates for many measurands, calling for a new approach to deliver robust BV estimates for safe clinical application. On this background, the Working Group on BV and the Task Group on the Biological Variation Database have developed a standard for evaluating studies on BV; the Biological Variation Data Critical Appraisal Checklist (BIVAC), a Minimum Dataset for BV studies and a meta-analysis approach for delivery of global BV estimates. These tools are used to populate the EFLM Biological Variation Database.

Committee for information and public relations

Dear members,

we invite you to participate in EFLM webinar by EFLM WG Distance Education and e-Learning “Monitoring of Internal Quality Control System Using Patient’s Data” which will be held by Professor of Clinical Biochemistry, Abdurrahman Coskun (University of Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey on 18th of June at 6 PM.

Please find more information about this webinar: https://elearning.eflm.eu/
Registration at: https://elearning.eflm.eu/enrol/index.php?id=40
The participation is free of charge.

Committee for information and public relations